GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PixarBio Corp (GREY:PXRB) » Definitions » Short Interest

PXRB (PixarBio) Short Interest


View and export this data going back to 2016. Start your Free Trial

What is PixarBio Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of PixarBio's Short Interest

For the Biotechnology subindustry, PixarBio's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PixarBio's Short Interest Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PixarBio's Short Interest distribution charts can be found below:

* The bar in red indicates where PixarBio's Short Interest falls into.


PixarBio Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PixarBio Corp (GREY:PXRB) » Definitions » Short Interest
Comparable Companies
VSAR ARCT ASX:ZLD TSXV:ATE ASX:ANR XPAR:OSE NTRP OSL:HBC XKRX:216400 LSE:HVO OSTO:ACTI BCLI LSE:SCLP ROCO:6580 ASX:BOT LSE:RLM NBY ASX:AHZ NAVB SPHS
Traded in Other Exchanges
N/A
Address
200 Boston Avenue, Suite 1875, Medford, MA, USA, 02155
Website
https://www.pixarbio.com
PixarBio Corp is a specialty pharmaceutical company focused on preclinical and clinical commercial development of therapeutic drug delivery systems for post-operative pain. The company's lead clinical candidate, NeuroRelease is a non-opioid / non-opiate preclinical stage product intended for the treatment of surgical pain, with planned future indications for chronic pain. NeuroRelease blocks nociceptive and neuropathic pain signals arising from temperature and pressure stimuli without affecting motor function, which is intended to allow for effective treatment without delaying post-surgical physical therapy.

PixarBio Headlines